Benefit of nicorandil using an immunologic murine model of experimental colitis

Benefit of nicorandil using an immunologic murine model of experimental colitis

Bibliographic Details
Main Authors:	Hosseini-Tabatabaei Azadeh, Esmaily Hadi, Rahimian Reza, Khorasani Reza, Baeeri Maryam, Barazesh-Morgani Ahmadreza, Sari-Aslani Fatemeh, Abdollahi Mohammad
Format:	Article
Language:	English
Published:	De Gruyter 2009-03-01
Series:	Open Life Sciences
Subjects:	nicorandil inflammatory bowel disease immunologic myeloperoxidase inflammatory cytokines 2,4,6-trinitrobenzene sulphonic acid (tnbs)
Online Access:	https://doi.org/10.2478/s11535-008-0047-0

Similar Items

On the benefits of silymarin in murine colitis by improving balance of destructive cytokines and reduction of toxic stress in the bowel cells
by: Esmaily Hadi, et al.
Published: (2009-06-01)

Investigation of the relationship between the Th17/IL-23 pathway and innate-adaptive immune system in TNBS-induced colitis in rats
by: İhsan Karaboga, et al.
Published: (2017-08-01)

Modified Method for Inducing Acute Intestinal Fibrosis in Rats Using 2,4,6-Trinitrobenzene Sulfonic Acid
by: WANG Yiru, et al.
Published: (2022-08-01)

Nicorandil-induced penile ulcerations: A case report and review of the penile cutaneous circulation
by: C.D. Jones, et al.
Published: (2016-09-01)

The Peptide LLTRAGL Derived from <i>Rapana venosa</i> Exerts Protective Effect against Inflammatory Bowel Disease in Zebrafish Model by Regulating Multi-Pathways
by: Yongna Cao, et al.
Published: (2024-02-01)

Electrolyzed Hydrogen Water Alleviates Abdominal Pain through Suppression of Colonic Tissue Inflammation in a Rat Model of Inflammatory Bowel Disease
by: Di Hu, et al.
Published: (2022-10-01)

Effects of Nicorandil on the Clinical and Laboratory Outcomes of Unstable Angina Patients after Coronary Angioplasty
by: Homa Falsoleiman, et al.
Published: (2016-09-01)

Anti-inflammatory effects of alosetron mediated through 5-HT3 receptors on experimental colitis
by: Azadeh Motavallian, et al.
Published: (2019-01-01)

Protective Effects of Taurine Chloramine on Experimentally Induced Colitis: NFκB, STAT3, and Nrf2 as Potential Targets
by: Seong Hoon Kim, et al.
Published: (2021-03-01)

Effect of Carbamylated Erythropoietin in a Chronic Model of TNBS-Induced Colitis
by: Inês Silva, et al.
Published: (2023-09-01)

Chronic Experimental Model of TNBS-Induced Colitis to Study Inflammatory Bowel Disease
by: Inês Silva, et al.
Published: (2022-04-01)

Anti-Inflammatory Effect of Topiramate in a Chronic Model of TNBS-Induced Colitis
by: Inês Silva, et al.
Published: (2022-08-01)

Mechanism of action and neuroprotective role of nicorandil in ischemic stroke
by: Maryam Owjfard, et al.
Published: (2024-02-01)

Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model
by: Rachel T. Sullivan, et al.
Published: (2021-06-01)

Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression
by: Max Lenz, et al.
Published: (2021-01-01)

Soluble Protein Hydrolysate Ameliorates Gastrointestinal Inflammation and Injury in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis in Mice
by: Jingjing Wei, et al.
Published: (2022-09-01)

Nicorandil decreases oxidative stress in slow‐ and fast‐twitch muscle fibers of diabetic rats by improving the glutathione system functioning
by: Sarai Sánchez‐Duarte, et al.
Published: (2021-07-01)

Intestinal anti-inflammatory effects of RGD-functionalized silk fibroin nanoparticles in trinitrobenzenesulfonic acid-induced experimental colitis in rats
by: Rodriguez-Nogales A, et al.
Published: (2016-11-01)

Effects of nicorandil on renal function and histopathology in rats with partial unilateral ureteral obstruction
by: Hayrettin Ozturk, et al.
Published: (2017-05-01)

MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION
by: Z. M. Sizova, et al.
Published: (2016-01-01)

ORAL TREATMENT WITH NICORANDIL AT DISCHARGE IS ASSOCIATED WITH REDUCED MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION
by: Y. Sakata, et al.
Published: (2012-10-01)

Effect of Aqueous Extract of Phenolic Compounds Obtained from Red Wine in Experimental Model of Colitis in Mice
by: Vanessa Mateus, et al.
Published: (2022-06-01)

Therapeutic potential of nicorandil beyond anti-anginal drug: A review on current and future perspectives
by: Dhirendra Singh, et al.
Published: (2024-04-01)

Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction
by: Anahid Safari, et al.
Published: (2021-07-01)

Nicorandil in the prevention of cardiac damage and type 4A myocardial infarction with planned percutaneous coronary intervention in patients with atherosclerosis of coronary arteries
by: G. N. Soboleva, et al.
Published: (2019-06-01)

The Safety of Nicorandil Therapy and the Relationship with Treatment Adherence in Patients with Stable Angina Pectoris (According to the NIKEA Observational Study)
by: Yu. V. Lukina, et al.
Published: (2022-09-01)

Effect of nicorandil on QT dispersion in patients with stable angina pectoris undergoing elective angioplasty: A triple-blind, randomized, placebo-controlled study
by: Homa Fal Suleimani, et al.
Published: (2017-08-01)

Mouse model of ulcerative colitis using trinitrobenzene sulfonic acid
by: Irfan Ahmad Rather, et al.
Published: (2015-10-01)

Nicorandil prevents sirolimus-induced production of reactive oxygen species, endothelial dysfunction, and thrombus formation
by: Ken Aizawa, et al.
Published: (2015-03-01)

Efficacy of Oral Nicorandil to Prevent Contrast-Induced Nephropathy in Patients with Chronic Renal Dysfunction Undergoing an Elective Coronary Procedure
by: Zeyuan Fan, et al.
Published: (2019-10-01)

PHARMACOLOGICAL PRECONDITIONING. FOCUS ON NICORANDIL
by: R. V. Gostishchev, et al.
Published: (2017-10-01)

ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

Inhibition of plasminogen activator inhibitor-1 attenuates against intestinal fibrosis in mice
by: Jin Imai, et al.
Published: (2020-04-01)

Conjugation with Tris Decreases the Risk of Ketoprofen-Induced Mucosal Damage and Reduces Inflammation-Associated Methane Production in a Rat Model of Colitis
by: Melinda Ugocsai, et al.
Published: (2023-09-01)

Intracoronary nicorandil induced hyperemia for physiological assessments in the coronary artery lesions
by: Xia Yang, et al.
Published: (2022-11-01)

Histopathological Evaluation of the Effect of Eugenol in a Model of Trinitrobenzenesulfonic Acid-Induced Colitis in Rats
by: Marinov V., et al.
Published: (2021-11-01)

Nicorandil directly and cyclic GMP-dependently opens K+ channels in human bypass grafts
by: Marija Marinko, et al.
Published: (2015-06-01)

THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY
by: S. Yu. Martsevich, et al.
Published: (2017-01-01)

Neuroprotective effect of nicorandil in 6-OHDA induced in vitro model of parkinson's disease
by: Ufuk Okkay, et al.
Published: (2022-03-01)

Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trial
by: Ye Z, et al.
Published: (2018-08-01)